CVAC | CureVac N.V. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.16 - 3.40
52 Week Range	2.2150 - 8.04
Beta	2.28
Implied Volatility	150.78%
IV Rank	33.48%
Day's Volume	428,129
Average Volume	821,811
Shares Outstanding	224,306,000
Market Cap	733,480,620
Sector	Healthcare
Industry	Biotechnology
IPO Date	2020-08-14

Valuation
Profitability
Growth
Health
P/E Ratio	-2.37
Forward P/E Ratio	N/A
EPS	-1.38
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	999
Country	Germany
Website	CVAC

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.

CVAC's peers: ABCL, BLUE, ABCM, BPMC, CYTK, NARI, MMSI, RARE, NTLA, MRTX, ZLAB, NTRA, IBRX, IOVA, MRNA, NVO, ONCY, RPRX, SAVA, VIR

*Chart delayed

Analyzing fundamentals for CVAC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is very weak. For more detailed analysis please see CVAC Fundamentals page.

Watching at CVAC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on CVAC Technicals page.